Blog: Depo-Provera

Pfizer and Depo-Provera: Another Example of a Company Failing to Warn Women About Risks in Products and Medicines

Oct 7, 2024

In recent years, there has been a growing awareness of how certain companies have failed to adequately warn female consumers about the risks associated with their products and medicines. From pharmaceuticals to cosmetics, several high-profile cases have highlighted the negligence of corporations in protecting women’s health. The most recent example is Pfizer’s failure to warn millions of users of Depo-Provera about the injection’s increased risk of causing brain and spinal cord tumors (meningiomas). When research revealed...

Informed Consent and Depo-Provera: Are Women Being Properly Informed?

Oct 7, 2024

Women deserve the right to make choices about their health, but only through full and accurate warnings and drug information can any woman make the decision that’s right for her. Women who aren’t properly informed about the risks of their birth control medications could be taking on serious health risks without even knowing it. That, along with the severe harm that has been linked to birth control injections in the form of an increased risk...

Depo-Provera Lawsuits: Pfizer Hid the Ugly Truth from Women

Oct 6, 2024

Kila Baldwin is one of the leaders of the Anapol Weiss Women's Health Litigation Team. Kila is currently investigating cases of women who used Depo-Provera and developed brain or spinal cord tumors (meningiomas). Lifestyle drugs are medications prescribed not to treat an illness, but rather to help in your lifestyle. Millions of women for decades have taken prescribed birth control medications to avoid getting pregnant. There are other non-drug alternatives, like condoms, but taking a...

Could Tumors Caused by Depo-Provera Have Been Avoided by a Safer Version Owned by Pfizer?

Oct 5, 2024

Shayna Slater, Anapol Weiss Women’s Health Ligitation Team Depo-Provera, a popular hormonal contraceptive, has been a go-to choice for many seeking birth control. Administered via injection every three months, it purported to offer convenience and effectiveness. However, there is now evidence that it also increased women’s risk of brain and spinal tumors, called meningiomas. A Safer Alternative Sadly, initial research suggests that Pfizer actually owned a safer alternative. While investigation continues, if Pfizer did, in fact, own a...

Health Implications: How the Depo-Provera Lawsuit Highlights Women's Health Concerns

Oct 4, 2024

The birth control shot, a contraceptive delivered by injection every 12 weeks, has been hailed as a convenient alternative for women who don’t want to take birth control pills daily. Unfortunately, recent research findings have raised serious concerns about the safety of this medication. The recent Depo-Provera lawsuits are the latest mass tort legislation arising out of women’s health concerns. For patients who did or currently do use Depo-Provera for birth control, it’s important to understand...

Depo-Provera Lawsuits: Yet Another Example of Women Fighting Back Against Harmful Drugs

Oct 4, 2024

By: Anapol Weiss Women’s Health Litigation Team Depo-Provera, the popular injectable contraceptive containing medroxyprogesterone acetate, has been marketed as a safe, convenient, long-term birth control solution. However, recent research has linked it to an increased risk of brain and spinal cord tumors (“meningiomas”). Depo-Provera: The Legal Fallout The first lawsuit against the drug’s manufacturer, Pfizer, was filed on October 1, 2024, accusing the pharmaceutical giant of failing to disclose the risks associated with long-term use of the drug...

Depo-Provera and Brain and Spinal Cord Tumors (Meningiomas): What you Need to Know

Sep 17, 2024

When it comes to managing birth control, women have numerous options available to them, from oral contraceptives to long-acting methods like Depo-Provera. Depo-Provera, an injectable form of birth control, has been a popular choice due to its convenience and efficacy. However, a recent study linked Depo Provera use to an increased risk of brain and spinal tumors called meningiomas. It is estimated that 1 in 5 women have used Depo-Provera at some point which makes...